Recent Articles from Investor Brand Network

Disseminated on behalf of Fairchild Gold Corp. (TSX.V: FAIR) (OTCQB: FCHDF) and may include paid advertising.

Roth Capital Partners announced the addition of Jack Terranova as Managing Director, Healthcare Investment Banking, Noah Huehnergarth as Executive Director, Institutional Sales, and Max Masucci as Managing Director and Senior Research Analyst, further strengthening its healthcare platform across investment banking, institutional sales, and equity research. The firm stated the hires enhance its integrated, sector-focused capabilities in life sciences, diagnostics, and therapeutics, supporting capital markets execution, investor connectivity, and strategic growth initiatives, as ROTH has participated in more than 600 healthcare transactions since 2010 totaling over $25 billion in value.

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

Xeriant (OTCQB: XERI) recently expanded the role of Brig. Gen. Blaine D. Holt (ret.), signaling a deeper commitment to disciplined innovation and advanced research. An article discussing this reads, “Holt’s appointment to lead Factor X marked the beginning of his formal involvement with Xeriant and expanded his responsibilities beyond advisory into active leadership of the company’s most forward-looking research initiatives. Xeriant recognized that Holt’s experience advising senior military and government leaders brought a critical perspective to the evaluation and development of advanced technologies with both commercial and strategic relevance…From a governance perspective, Holt’s involvement as the operational leader of Factor X reflects Xeriant’s effort to tightly integrate strategic oversight with innovation execution. The company has framed this structure to reduce friction between vision and implementation, ensuring that advanced research efforts remain aligned with long-term corporate objectives… More broadly, Holt’s increasing participation underscores Xeriant’s intent to position itself at the intersection of advanced technology development and practical application.”

Authorities in Russia have started restricting residents’ access to Telegram, one of the most widely used social media apps. This effort is geared at pushing Russians towards local alternatives that the government tightly controls .

Crypto markets are known for their speed, size, and surprises. But even in this fast-moving world, what happened at a South Korean crypto exchange shocked many people. A simple mistake turned into a $40 billion problem almost instantly.

Sonim Technologies (NASDAQ: SONM) changed its corporate name to DNA X, Inc. concurrent with its previously announced asset sale to NEXA(R) formerly Social Mobile. The company stated proceeds from the transaction are expected to fund debt retirement and provide working capital for its digital asset management operations, with DNA X, Inc. moving forward as operator of the DNA X digital asset trading platform acquired in December 2025. The company will temporarily retain the Nasdaq trading symbol SONM, with a planned transition to DNAX in the near future.

HeartBeam (NASDAQ: BEAT) was recently recognized among a select group of medical device companies featured in a January industry roundup highlighting recent U.S. Food and Drug Administration (“FDA”) clearances and approvals across the sector. The recognition underscores HeartBeam’s progress as it advances a novel approach to cardiac diagnostics through its HeartBeam System, a cable-free, high-fidelity ECG platform designed to capture the heart’s electrical signals from three distinct directions and synthesize them into a 12-lead ECG for arrhythmia assessment.

Annovis Bio (NYSE: ANVS) announced that an independent Data and Safety Monitoring Board has issued a positive recommendation supporting continuation of its ongoing pivotal Phase 3 Alzheimer’s disease clinical trial of buntanetap without modification following a 6-month safety review. The DSMB found no safety concerns after evaluating unmasked data, with safety outcomes in Alzheimer’s patients consistent with those observed in Parkinson’s patients at the same time point, and additional safety reviews planned at 12 and 18 months. The Phase 3 trial (NCT06709014), currently 40% complete and recruiting across the United States, is expected to deliver a symptomatic efficacy readout in early 2027 and a disease-modifying readout in early 2028.

Renewal Fuels (OTC: RNWF) announced the appointment of Dwight Cartwright as Chief Operating Officer and member of its Board of Directors, strengthening leadership as the company advances the Texatron(TM) fusion platform toward commercial deployment. Cartwright brings senior experience across operations, manufacturing, infrastructure development and large-scale, technology-driven organizations, and will oversee day-to-day operations, manufacturing and supply chain readiness, infrastructure buildout, safety and quality systems, and organizational execution. Leadership highlighted his operational discipline and experience scaling complex programs as critical to supporting American Fusion’s next phase of growth and deployment.

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

SOLOWIN HOLDINGS (NASDAQ: AXG) announced it has entered into a securities purchase agreement with Streeterville Capital, LLC for up to $100 million in financing through the issuance of one or more pre-paid purchases for AXG class A ordinary shares. The company completed an initial pre-paid purchase of approximately $5.415 million before discounts and expenses, with additional purchases subject to mutual consent. Proceeds are expected to support expansion of AXG’s stablecoin and asset tokenization businesses, advance research and development in artificial intelligence and blockchain security technologies, and fund global market expansion, with further transaction details disclosed in its Form 6-K and Prospectus Supplement on Form 424B5 filed Feb. 9, 2026.

This article has been disseminated on behalf of New Pacific Metals Corp. and may include paid advertising.

Oncotelic Therapeutics (OTCQB: OTLC) and Sapu Bioscience announced key advancements in their global intellectual property portfolio supporting OT-101, a proprietary TGF-β antisense therapeutic platform, with allowed patent claims in Australia covering OT-101 (SEQ ID NO:9) for the treatment of Parkinson’s Disease, including associated sleep-related symptoms, and granted utility model patents in China and Germany for an intracranial continuous infusion delivery device. The company stated the expanded protection spans therapeutic use claims, CNS delivery methods, device-enabled administration and broader oncology and neurology applications, forming an integrated commercialization platform intended to strengthen long-term defensibility, support strategic partnerships and enhance shareholder value, with additional data presentations planned at BIO-Europe Spring March 23—25, 2026.

SuperCom (NASDAQ: SPCB) announced a new electronic monitoring service provider contract in Louisiana, marking its entry into its 16th new U.S. state and 17th new service provider partnership since mid-2024. Under the agreement, SuperCom will serve as the primary EM technology partner for a Louisiana-based provider operating statewide supervision programs, transitioning existing GPS tracking operations to its proprietary PureSecurity(TM) platform under a recurring revenue model based on daily active units. Management stated the agreement reflects continued competitive incumbent displacement and supports the company’s disciplined U.S. expansion strategy focused on scalable technology deployment and long-term partnership growth.

NanoViricides, Inc. (NYSE American: NNVC) announced it has filed an application for Orphan Drug Designation for NV-387 as a treatment for MPox with the U.S. FDA Office of Orphan Products Development. If granted, the designation would provide incentives including tax credits for qualified clinical trials, exemption from certain user fees and potential seven years of market exclusivity following approval. The company highlighted ongoing global MPox concerns, limited therapeutic options and challenges associated with existing smallpox antivirals such as TPOXX(R) and TEMBEXA(R), noting continued viral mutations and the need for an effective therapeutic solution.

Soligenix (NASDAQ: SNGX) issued a shareholder update from President and CEO Dr. Christopher J. Schaber outlining anticipated 2026 milestones across its late-stage rare disease pipeline, including top-line data from the Phase 3 FLASH2 trial of HyBryte in early-stage cutaneous T-cell lymphoma expected in the second half of 2026, with an interim analysis approaching in the second quarter and 66 of 80 patients enrolled as of Feb. 10. The letter also reviewed positive Phase 2a data for SGX945 (dusquetide) in Behçet’s Disease published in Rheumatology (Oxford), encouraging Phase 2a psoriasis results for SGX302, ongoing strategic evaluations including partnership and M&A opportunities, and the company’s cash position of approximately $10.5 million as of Sept. 30, 2025, with runway projected through 2026.

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

The International Energy Agency expects nuclear power and renewable energy to supply roughly half of global electricity demand by 2030, even as worldwide power consumption accelerates sharply. In its latest Electricity 2026 outlook, the agency points to rising industrial electrification, electric vehicle adoption, expanding data centers, and growing AI workloads as the primary drivers behind a surge in electricity use across advanced and emerging economies.

Bitcoin slid sharply on Thursday evening, briefly dipping below the $61,000 mark as confidence continued to erode in the crypto that was once promoted as a modern substitute for gold and a reliable store of value.

Gen Z grew up with smartphones, social media, and instant connections, so many people assume online dating should feel natural to them. But for a growing number of young adults, dating apps have become more frustrating than exciting. Even though these platforms are meant to make finding love easier, many Gen Zs say the experience feels tiring, confusing, and far from romantic.

This article has been disseminated on behalf of Energy Fuels Inc. and may include paid advertising.

Federal hemp regulations are set to shift dramatically in nine months, a change that industry leaders warn could effectively outlaw most consumable cannabinoid products. In the meantime, the FDA faces a looming deadline to provide guidance that could shape the future of hemp policy.

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements.

GridAI Technologies (NASDAQ: GRDX) is focused on advancing opportunities at the intersection of artificial intelligence and energy infrastructure following its acquisition of Grid AI, Inc. “The company recently announced that it had named Marshall Chapin as the CEO of the company’s GridAI, Inc. subsidiary,” an article discussing the company reads. “GridAI, Inc. is developing next-generation grid and power-management software for hyperscale artificial-intelligence (‘AI’) data-center campuses, providing an AI-driven energy orchestration platform that coordinates distributed energy resources across multiple scales. With the fast-growing AI-data-center market anticipated to reach $1 trillion by 2030, the need for intelligent power orchestration solutions has become critical… GridAI Inc.’s new CEO has decades of leadership experience across the grid-optimization, energy-transition, and distributed-energy sectors, and, since March 2025, Chapin has served as the Interim CEO of Amp X, an AI-driven grid-edge platform, which is also a GridAI subsidiary. His appointment shows GridAI’s commitment to deploying a top-of-the-line orchestration engine that’s able to manage the power and flexibility demands of the massive and growing AI data center market.”

Micropolis (NYSE American: MCRP) was featured in a recent article that discussed its efforts to expand its industrial robotics portfolio through unveiling a new platform designed for heavy-duty, continuous operations. “The platform was revealed in January at the UMEX 2026 exhibition in Abu Dhabi, where it was showcased on the stand of EDGE Group, the UAE’s state-backed advanced technology and defense manufacturer,” the publication reads. “The Autonomous Logistics Platform is built on Micropolis’ M01 base vehicle and is intended for use in controlled industrial settings rather than public roads. Target environments include manufacturing facilities, industrial zones, logistics corridors, and other secured or access-restricted areas where predictable routes and repeatable missions are critical. The company describes the system as a response to the growing need for reliable, autonomous transport of goods and equipment within large industrial campuses.”

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is focused on enhancing established cancer therapies by targeting a fundamental biological pathway involved in tumor survival and resistance. “Rather than developing standalone treatments, LIXTE is advancing a first-in-class approach designed to increase the effectiveness of chemotherapy and immunotherapy across multiple cancer indications,” reads a recent article. “At the center of LIXTE’s strategy is protein phosphatase 2A, or PP2A, an enzyme that plays a critical role in regulating cell growth, DNA repair, and survival signaling. In many cancers, PP2A activity enables tumor cells to recover from the damage caused by treatment, contributing to resistance and disease progression… LIXTE’s proprietary compound, LB-100, is a small-molecule PP2A inhibitor designed to temporarily disrupt these repair mechanisms at the moment when cancer cells are exposed to therapy. Preclinical research cited in the company’s presentation shows that this disruption can make tumor cells more vulnerable to chemotherapy and immunotherapy, increasing treatment effectiveness without introducing a new cytotoxic agent.”

Datavault AI (NASDAQ: DVLT) is highlighted in the Winter 2026 issue (p. 27) of RADIO + TELEVISION BUSINESS REPORT, which examines the company’s patented ADIO technology and real-time bias meter initiative. ADIO leverages embedded, inaudible audio signals to activate mobile viewer responses, enabling live polls, feedback and interactive engagement during broadcast and streamed programming. The publication points to the technology’s pilot deployment with Fintech.TV as an early stage proving ground ahead of broader rollout across streaming and broadcast platforms.

SPACSphere Acquisition (NASDAQ: SSACU) announced the closing of its initial public offering of 17,250,000 units at $10.00 per unit, including 2,250,000 units issued pursuant to the full exercise of the underwriter’s over-allotment option, generating gross proceeds of $172.5 million. The units began trading on the Nasdaq Global Market on Feb. 6, 2026, under the symbol “SSACU,” with underlying Class A ordinary shares, warrants and share rights expected to trade separately as “SSAC,” “SSACW” and “SSACR,” respectively. An amount equal to $10.00 per unit was placed in trust, and the company will seek a merger or similar business combination, focusing on digital assets, technology and healthcare, with D. Boral Capital LLC acting as sole book-running manager.

Wearable Devices (NASDAQ: WLDS) announced the launch of ai6 Labs, a closed-loop ecosystem designed to bridge human intent with digital systems through non-invasive electromyography and its Mudra technology platform. The initiative integrates foundational neural research, commercialization and rapid AI experimentation through three pillars: a foundation layer built on the Large MUAP Model and Brain-AI Bus architecture to decode biological intent into machine-readable data; a revenue and ecosystem growth component aimed at monetizing research outcomes; and an AI accelerator focused on advancing concepts across areas such as agentic workflows and edge AI. Chief Executive Officer Asher Dahan said the launch positions the company to capitalize on accelerating demand for AI wearables, gesture control in extended reality and non-invasive brain-computer interface technologies.

Colombier Acquisition (NYSE: CLBR U) announced the closing of its initial public offering of 29,900,000 units, including 3,900,000 units issued through the underwriters’ over-allotment option, at $10.00 per unit for total gross proceeds of $299 million. Each unit consists of one Class A ordinary share and one-eighth of one redeemable warrant, with whole warrants exercisable at $11.50 per share. The units trade on the New York Stock Exchange under the symbol “CLBR U,” with underlying shares and warrants expected to trade separately as “CLBR” and “CLBR WS.” The company placed $299 million in trust and will seek to complete a merger or similar business combination, with Roth Capital Partners serving as sole book running manager and StoneX Financial Inc. acting as manager.

Renewal Fuels (OTC: RNWF), doing business as American Fusion, announced it has engaged IBN to support its corporate communications strategy following its completed merger with Kepler Fusion Technologies. The company has repositioned its operations toward the development and long-term commercialization of deployable fusion power systems for industrial and infrastructure applications, advancing its technology and deployment roadmap through a wholly owned subsidiary. Under the agreement, IBN will leverage its investor-focused distribution network, including more than 5,000 syndication outlets and InvestorWire services, to expand awareness among investors, journalists and the broader market as Renewal Fuels pursues disciplined governance, intellectual property development and regulatory readiness within a public-company framework.

Datavault AI (NASDAQ: DVLT) announced that Chief Executive Officer Nate Bradley hosted a private, invitation-only dinner Tuesday evening at Mar-a-Lago for institutional investors, high-net-worth individuals and senior government officials, following earlier meetings with a separate group of strategic investors. Discussions focused on the company’s execution roadmap, platform capabilities and long-term positioning in data infrastructure, digital engagement and real-world asset tokenization. The engagements follow recent visibility from Super Bowl LX weekend activations and a stockholder letter highlighting $49 million in fourth-quarter 2025 tokenization and technology licensing agreements, record fiscal 2025 revenue performance, expectations for at least $30 million in fiscal 2025 revenue and plans to report fourth-quarter results on Feb. 15, 2026.

OptimumBank Holdings (NYSE American: OPHC) announced that its management team will host a conference call and live webcast on Wednesday, Feb. 18, 2026, at 10 a.m. ET to discuss financial results for the fourth quarter and full year ended Dec. 31, 2025, and provide a business update. The company released its fourth-quarter and full-year earnings on Feb. 2, 2026, and invited current and prospective investors to register for the webcast, with additional information available by contacting Seth Denison at SDenison@OptimumBank.com

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

Rail Vision (NASDAQ: RVSN) issued a corporate update from Chief Executive Officer David BenDavid outlining key 2025 milestones and strategic priorities for 2026. The company reported commercial advancements including a MainLine system order from a leading Central American freight operator, a $335,000 follow-on order from a Latin American mining company and expanded collaboration with Israel Railways, which highlighted Rail Vision’s AI technology at CES 2026. Rail Vision also announced a memorandum of understanding with Sujan Industries in India and the launch of a proof-of-concept project there in January 2026. Additionally, the company completed the acquisition of a 51% stake in Quantum Transportation, positioning the firm to integrate quantum computing and AI capabilities into its rail safety platforms as it focuses on converting pilots into deployments, expanding geographically and scaling sales efforts in 2026.

Greenwave Technology Solutions (NASDAQ: GWAV) announced that its board of directors appointed Chelsea Pullano as chief financial officer, effective Feb. 5, 2026. The appointment follows the company’s Jan. 2, 2026, scope of work agreement with MACK Financial Solutions LLC, under which MACK will provide bookkeeping, financial reporting and SEC reporting services, with Pullano serving as part-time CFO. Pullano, co-founder and CEO of MACK since May 2023, previously served as chief financial officer of Creatd Inc. from June 2020 to May 2023 and as director of finance at Lucosky Brookman LLP from September 2024 to March 2025.

Perpetuals.com (NASDAQ: PDC), a fintech company focused on AI-driven digital asset trading solutions and regulated market infrastructure, announced that it has completed a pilot of its BayesShield(TM) artificial intelligence system, indicating that the technology would have successfully filtered out 92% of losing retail trades in Bitcoin perpetual futures based on a year-long backtest of real trading activity ( https://ibn.fm/Vbl3F ).

Mass General Brigham researchers have developed a new AI model that can estimate brain age, assess a patient’s risk of developing dementia, and help predict survival outcomes for brain cancer using routine MRI scans. The system, created within the Harvard-affiliated health network, is designed to pull multiple clinical signals from a single brain image rather than being trained for one narrow diagnostic task.

The market for quantum computing is expected to grow very fast over the next few years, with experts predicting it could reach about $8.7 billion by 2031. This rapid growth shows how important quantum technology is becoming as industries look for more powerful ways to solve complex problems that traditional computers struggle with.

On Monday, gold started the week on a high, closing the day with gains of 2% to put the metal on firm footing after it had climbed to a record high of $5,106 earlier in the day. Silver also registered gains of 7% on the day, reviving expectations that precious metals could be set to regain their upward momentum.

Octane, a Southern California innovation organization, will host its second annual Neuro Tech Forum on March 26–27, 2026, at the VEA Newport Beach. The two-day event is set to bring together investors, physicians, and industry leaders to explore emerging opportunities in neurotechnology. The forum lineup will feature keynote speaker Nick Hopkins, panel discussions on digital health, brain-computer interfaces (“BCI”), neuromodulation, neurovascular innovation, and treatments for neurological and psychiatric disorders, as well as live pitches from six neuroscience and vascular startups. Emceed by Jojo Platt, the forum aims to connect innovative companies with Octane’s network of angel investors, venture capital firms, strategic partners, and medical leaders, while highlighting advances in areas such as endovascular therapies and wearable and implantable BCI technologies.

President Donald Trump’s executive order issued on December 18 signaled a shift in US medical cannabis policy, opening new paths for research and fueling a wave of mergers and acquisitions across the sector. However, one essential issue remains unresolved: how will patients receive medical marijuana in a way that resembles standard healthcare?

Electronic Servitor Publication Network (OTC: XESP), a market disruptor for B2B companies using cutting-edge technology to reach target markets, has developed and is commercializing its Digital Engagement Engine(TM). The solution combines automation, unique data management and microservices architecture to elevate digital content and drive better digital interactions within current and new communities. “The company anchored the development of the Digital Engagement Engine(TM) in data analysis and smart technology, creating a tech stack that can identify even the narrowest of niches within clients’ respective target markets, tailor content to meet their exact needs, and deliver the content to them right when they need it,” a recent article reads. “Remarkably, XESP’s approach is not lifted from the conventional customer experience (‘CX’) playbook; it is rather unique. And as the company’s CEO Peter Hager explained in an interview with Proactive, this uniqueness is responsible for making the company good at what it does. ‘We just took an immense amount of focus on what happens when you’re not face to face with your customers. Many people look at the customer experience as a face-to-face [interaction] or just the brand, but they haven’t really followed the journey of the customer when they’re not face to face,’ explained Hager. XESP resolved to tackle the underlying problem by creating a system that allows client companies to sense and respond to what their users and customers are looking for when interacting with them digitally. This approach, according to Hager, created an edge.”

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging artificial intelligence to accelerate oncology drug discovery and development, announced that Chief Executive Officer and President Panna Sharma will present at the 7th Glioblastoma Drug Development Summit, taking place Feb. 17–19, 2026, in Boston. During a Day Two presentation on Feb. 19, Mr. Sharma will highlight how the Company’s RADR® AI and machine learning platform supported the development of STAR-001, a brain-penetrant therapeutic candidate, including insights into mechanism of action, biomarker identification, indication selection, and novel combination strategies for aggressive CNS cancers such as glioblastoma and ATRT.

Olenox Industries (NASDAQ: OLOX) announced the appointment of Erik Blum and Adam Falkoff to its Board of Directors, effective Feb. 6, 2026. The appointments fill existing board vacancies, with both directors serving until the Company’s 2025 Annual Meeting of Shareholders and participating in the Company’s non-employee director compensation program, as Olenox adds leadership experience spanning public company turnarounds, corporate finance, public policy, and global strategic advisory.

MedWell Ai (OTCQB: MWAI) announced that it has signed a letter of intent to create a vertically integrated health, wellness, and longevity platform organized across three core divisions: national pharma distribution and telemedicine, a nationwide portfolio of surgical, cosmetic, and men’s health centers, and an advanced biologics and product innovation group. The proposed consolidation includes Ageless Cosmetic Surgery Centers, Apollo BioWellness and its biologics subsidiary, and MedWell USA, with the combined company projecting more than $25 million in annual revenue in 2026 based on trailing 2025 revenues of $14 million, assuming successful closings and adequate funding, as parties move forward with due diligence targeting transaction completion within 60 days.

White Pearl Acquisition (NYSE: WPACU) announced that it closed its initial public offering on Feb. 3, 2026, issuing 11,500,000 units at $10.00 per unit, including 1,500,000 units sold pursuant to the full exercise of the underwriters’ over-allotment option. The units began trading on the New York Stock Exchange on Feb. 2, 2026, under the symbol “WPACU,” with each unit consisting of one Class A ordinary share and one right to receive one-fifth of one Class A ordinary share upon completion of an initial business combination, while the Company’s Class A ordinary shares, units, and rights trade under the symbols “WPAC,” “WPACU,” and “WPACR,” respectively, and D. Boral Capital LLC acted as sole bookrunner for the offering.

From lab research to clinical application, photodynamic therapy (“PDT”) is emerging as a powerful treatment approach that uses light and chemistry to selectively target diseased tissue. As this modality gains attention for its precision and safety profile, Soligenix (NASDAQ: SNGX) is developing light-activated therapies designed to treat cutaneous T-cell lymphoma (“CTCL”) and other inflammatory skin diseases using targeted photodynamic mechanisms that aim to improve outcomes while minimizing systemic toxicity.

NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage antiviral developer, announced that it has filed an application with the U.S. Food and Drug Administration Office of Orphan Products Development for Orphan Drug Designation for NV-387 as a treatment for measles. If granted, the designation would make the Company eligible for incentives including tax credits for qualified clinical trials, exemptions from certain FDA user fees, and up to seven years of market exclusivity following approval, supporting the regulatory development of NV-387 amid rising measles cases in the United States and globally.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

Perpetuals.com (NASDAQ: PDC), a fintech company focused on AI-driven digital asset trading solutions and regulated market infrastructure, is positioning itself at the intersection of traditional financial infrastructure and blockchain-based systems, targeting institutions that want exposure to digital assets without stepping outside regulated frameworks. The company develops software that allows regulated trading venues to operate continuously, with self-clearing and blockchain-native settlement replacing legacy post-trade processes.

VolitionRx (NYSE American: VNRX), a multi-national epigenetics company, announced the appointment of Medical & Biological Laboratories Co. Ltd. as a non-exclusive distributor of its Nu.Q(R) Discover assays in Japan. The agreement expands access to Volition’s nucleosome-based biomarker assays for drug developers and researchers in the Japanese market and builds on the Company’s growing global collaborator network, as Nu.Q(R) Discover now serves close to 100 clients worldwide, including leading pharmaceutical and diagnostic companies using the assays to support disease research, drug development, and late-stage clinical trials.

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.

Perpetuals.com (NASDAQ: PDC) announced the launch of Barrier Futures, a proprietary, MiFID II-compliant derivatives product designed as a regulated alternative to offshore perpetual futures and retail contracts for difference, addressing markets that collectively represent multi-hundred-trillion dollars in annual notional volume. The Company said Barrier Futures offer defined-risk positions without margin calls while enabling brokers to participate through a scalable B2B model that includes trading fee revenue shares, spread participation, and white-label licensing, with the platform expected to go live for qualified brokers in March 2026 and initial partnerships targeted for Q1.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

As an abundant element in the universe, hydrogen has an extensive range of applications, among them its use as a carrier of clean energy in fuel cells in cars and in oil refining. With the automotive industry continuously expanding, the demand for alternative fuels like hydrogen has grown exponentially.

China has begun producing sodium-ion electric vehicles, moving ahead of Western automakers like Tesla and opening the door to a new category of EVs. CHANGAN Automobile recently unveiled an electric passenger car powered by a sodium-ion battery supplied by CATL, with volume production expected to begin later this year.

While people have been quick to blame health insurers for the skyrocketing cost of health care in the U.S., the reality of the situation is more nuanced, and other factors have played a much bigger role in driving up costs. We explore some of those less-reported drivers of the high cost of health care in the country.

Military flight training has long followed a familiar formula: structured lessons, carefully staged challenges, and instructors judging progress only by performance. In the Netherlands, researchers are now testing a system that could change that model by allowing simulators to respond directly to what is happening inside a pilot’s brain .

Earth Science Tech (OTC: ETST), a strategic holding company focused on acquiring and scaling high-potential operating businesses, announced that it will report financial results for the three months ended Dec. 31, 2025, after the close of trading on Tuesday, Feb. 17, 2026.

A new analysis shows that roughly 90% of China’s investment growth last year came from green energy, underscoring how decisively clean industries now drive the country’s economic expansion. According to research from the Center for Research on Energy and Clean Air published by Carbon Brief , clean energy sectors propelled more than 90% of capital growth in 2025 and now rival all but seven national economies in scale.

Concerns about China’s stance on digital assets have resurfaced as Bitcoin drifts deeper into bear market conditions. Chinese authorities have announced a tighter interpretation of their existing cryptocurrency ban, moving to explicitly outlaw activities tied to real-world asset (RWA) tokenization and unapproved stablecoins tied to the yuan.

On Friday, China launched an experimental reusable spacecraft in a mission that was shrouded in secrecy like the previous three such launches. Announcements about this mission were reported by Xinhua, a state-run media organization.

Forward Industries (NASDAQ: FWDI) the leading Solana treasury company, announced that it will host a conference call on Thursday, Feb. 12, 2026, at 5 p.m. Eastern Time to discuss its financial and operating results for the three months ended Dec. 31, 2025, with financial results to be released in a press release prior to the call; the Company’s executive team will host the call and webcast presentation, followed by a question-and-answer period.

Ohio Attorney General Dave Yost has approved the official title and summary language for a proposed referendum that seeks to roll back the state’s recent changes to its recreational marijuana laws. The decision clears a major procedural hurdle for advocates who want voters to weigh in on Senate Bill 56, a measure adopted by lawmakers late last year.

XTI Aerospace (NASDAQ: XTIA), an aerospace technology company focused on scaling its Drone Nerds, LLC subsidiary, outlined its operating leverage, expanding customer base, and near-term value creation initiatives during its Shareholder Town Hall held Feb. 5, 2026. Management provided full-year 2026 revenue guidance for the first time, projecting revenue to exceed $160 million, representing approximately 30% growth, and emphasized disciplined execution following the November 2025 acquisition of Drone Nerds, which has positioned the Company as a scaled enterprise drone and unmanned aircraft systems platform serving enterprise, government, and defense-adjacent customers.

Safe Pro Group Inc. (NASDAQ: SPAI), a developer of AI-powered defense and security solutions, is presenting at the 2026 Defence Leaders Combat Engineer & Logistics Conference (“CEL26”) in Krakow, Poland ( https://ibn.fm/u4HK9 ).

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, recently acquired Liora Technologies, a company that’s pioneering proton therapy systems for treating tumors in various types of cancers.

Solowin Holdings (NASDAQ: AXG), a financial technology firm bridging traditional and digital assets, announced a partnership with Taobao Shangou, a subsidiary of Alibaba Group, and Hangzhou Bossen to deploy an integrated model combining high-quality carbon assets, consumer platform incentives, and on-chain carbon credit circulation. The collaboration leverages AXG’s Ferion asset tokenization platform to enable compliant, transparent lifecycle management of carbon assets, which are embedded into Taobao Shangou’s consumer incentive system to reward users for low-carbon behaviors such as green delivery and sustainable purchasing choices, supporting China’s national and provincial carbon peaking and carbon neutrality objectives and establishing a scalable framework for inclusive carbon reduction.

Oragenics (NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics using proprietary intranasal delivery technology, today outlined targeted milestones for 2026 as it advances ONP-002, a novel intranasal neurosteroid, toward Phase 2 clinical development. The Company is preparing to initiate a Phase 2a clinical trial of ONP-002 in Australia for the treatment of concussion and mild traumatic brain injury (mTBI), positioning the candidate as a potential first-in-class pharmacological therapy for a large and underserved global market following positive preclinical and Phase 1 safety and efficacy results.

Renewal Fuels (OTC: RNWF), also known as American Fusion, announced the appointment of Dr. John E. Brandenburg, Ph.D., as chief technology officer of Kepler Fusion Technologies, effective immediately. Dr. Brandenburg is a senior plasma physicist with more than four decades of experience spanning fusion energy, advanced propulsion, and applied plasma physics, and brings deep technical expertise to the Company’s mission of commercializing its Texatron(TM) aneutronic fusion platform. His career includes senior scientific roles at Lawrence Livermore National Laboratory, Sandia National Laboratories, The Aerospace Corporation, the Florida Space Institute at Kennedy Space Center, and Orbital Technologies Corporation, along with service under multiple U.S. government security clearances supporting sensitive defense and energy research programs.

Investors are responding positively to Meta’s decision to keep increasing artificial intelligence spending, even as fears grow that the AI boom could be inflating a bubble . While concerns about a potential bust are becoming more common, Meta’s latest earnings suggest that, for now, the market is still willing to back heavy investment, particularly when it produces clear financial results.